Powered by
Nexstim Plc Signs an Independent Selling Representative Agreement in the U.S. with JTec Surgical, Inc.
Mar 22, 2017 - Thomson Reuters ONE

Press release, Helsinki, 22 March 2017 at 3 pm

Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical technology company with a pioneering navigated non-invasive brain stimulation system, announces that its wholly owned subsidiary Nexstim Inc. has signed a new Independent Selling Representative Agreement in the U.S. with JTec Surgical, Inc. to represent the Nexstim Brain Mapping (NBS) system. The NBS system is used for the pre-surgical mapping of the speech and motor cortic

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox